Enterprise Financial Services Corp (EFSC)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Buy
7,001
+80
+1% +$4.66K 0.22% 86
2025
Q4
$373K Sell
6,921
-597
-8% -$28.7K 0.19% 94
2025
Q3
$339K Buy
7,518
+204
+3% +$9.53K 0.17% 96
2025
Q2
$339K Sell
7,314
-872
-11% -$42.8K 0.18% 103
2025
Q1
$499K Sell
8,186
-210
-3% -$12.2K 0.3% 73
2024
Q4
$475K Sell
8,396
-80
-0.9% -$4.47K 0.26% 76
2024
Q3
$439K Sell
8,476
-775
-8% -$36.4K 0.26% 82
2024
Q2
$384K Sell
9,251
-503
-5% -$22.5K 0.24% 88
2024
Q1
$529K Sell
9,754
-1,055
-10% -$53.7K 0.32% 71
2023
Q4
$555K Sell
10,809
-2,390
-18% -$125K 0.34% 67
2023
Q3
$766K Sell
13,199
-804
-6% -$49.3K 0.53% 46
2023
Q2
$895K Buy
14,003
+258
+2% +$17.3K 0.57% 43
2023
Q1
$953K Sell
13,745
-280
-2% -$19.7K 0.62% 40
2022
Q4
$1.01M Buy
14,025
+70
+0.5% +$5.28K 0.7% 37
2022
Q3
$992K Sell
13,955
-353
-2% -$25.6K 0.74% 27
2022
Q2
$1.1M Buy
14,308
+340
+2% +$25.9K 0.21% 84
2022
Q1
$1.02M Buy
13,968
+257
+2% +$17.3K 0.17% 106
2021
Q4
$855K Sell
13,711
-18,763
-58% -$1.1M 0.13% 130
2021
Q3
$1.92M Buy
32,474
+17,222
+113% +$1.13M 0.25% 89
2021
Q2
$1.02M Sell
15,252
-444
-3% -$29K 0.16% 93
2021
Q1
$990K Sell
15,696
-196
-1% -$12.2K 0.18% 86
2020
Q4
$986K Sell
15,892
-1,106
-7% -$68K 0.19% 79
2020
Q3
$1.02M Sell
16,998
-666
-4% -$40.1K 0.21% 73
2020
Q2
$1.04M Sell
17,664
-6,170
-26% -$369K 0.22% 73
2020
Q1
$1.33M Buy
23,834
+728
+3% +$44.5K 0.34% 57
2019
Q4
$1.48M Sell
23,106
-453
-2% -$25.9K 0.32% 60
2019
Q3
$1.19M Sell
23,559
-2,833
-11% -$133K 0.27% 68
2019
Q2
$1.2M Sell
26,392
-3,699
-12% -$172K 0.26% 70
2019
Q1
$1.44M Buy
30,091
+13,899
+86% +$692K 0.31% 56
2018
Q4
$842K Sell
16,192
-418
-3% -$22.5K 0.53% 44
2018
Q3
$1.03M Sell
16,610
-265
-2% -$15.7K 0.54% 37
2018
Q2
$934K Sell
16,875
-400
-2% -$21.6K 0.47% 45
2018
Q1
$1.09M Buy
17,275
+5,650
+49% +$363K 0.56% 37
2017
Q4
$713K Buy
11,625
+993
+9% +$62.1K 0.35% 60
2017
Q3
$678K Sell
10,632
-11,662
-52% -$681K 0.34% 61
2017
Q2
$1.24M Sell
22,294
-149
-0.7% -$8.11K 0.62% 34
2017
Q1
$1.22M Sell
22,443
-255
-1% -$14K 0.6% 34
2016
Q4
$1.33M Buy
22,698
+12,001
+112% +$656K 0.67% 31
2016
Q3
$577K Sell
10,697
-509
-5% -$32.7K 0.33% 63
2016
Q2
$824K Buy
11,206
+3,206
+40% +$227K 0.49% 43
2016
Q1
$511K Sell
8,000
-78
-1% -$4.92K 0.31% 64
2015
Q4
$556K Buy
8,078
+586
+8% +$38.7K 0.33% 69
2015
Q3
$444K Sell
7,492
-103
-1% -$6.53K 0.28% 74
2015
Q2
$505K Sell
7,595
-228
-3% -$15K 0.3% 73
2015
Q1
$505K Buy
7,823
+2,907
+59% +$182K 0.3% 72
2014
Q4
$291K Buy
4,916
+170
+4% +$9.59K 0.18% 111
2014
Q3
$243K Sell
4,746
-3,874
-45% -$194K 0.15% 116
2014
Q2
$418K Sell
8,620
-731
-8% -$36K 0.25% 79
2014
Q1
$486K Buy
9,351
+44
+0.5% +$2.34K 0.3% 62
2013
Q4
$494K Buy
9,307
+102
+1% +$5.2K 0.29% 61
2013
Q3
$426K Buy
9,205
+11
+0.1% +$483 0.27% 67
2013
Q2
$411K Buy
+9,194
New +$399K 0.28% 67

Other funds holding BMY

Enterprise Financial Services Corp (EFSC)'s BMY Position: Q1 2026 in Review

Enterprise Financial Services Corp (EFSC) increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, buying an estimated $4.66K and bringing the position to 7,001 shares worth $425K. The position accounts for 0.22% of the portfolio, ranked #86.

Enterprise Financial Services Corp (EFSC) first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.92M in Q3 2021. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Enterprise Financial Services Corp (EFSC) held 7,001 shares of Bristol-Myers Squibb worth $425K as of Q1 2026.
  • Enterprise Financial Services Corp (EFSC) bought 80 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.66K.
  • Bristol-Myers Squibb made up 0.22% of Enterprise Financial Services Corp (EFSC)'s portfolio in Q1 2026, its #86 holding.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Enterprise Financial Services Corp (EFSC)'s Bristol-Myers Squibb position peaked at $1.92M in Q3 2021.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2026, filed 5 May 2026.